Cilostazol improves systemic insulin resistance in diabetic db/db mice by suppressing proinflammatory cytokine production in macrophage and ameliorating insulin signaling in adipocyte.
- Sasaoka, T. (Speaker)
Activity: Talk or presentation › Oral presentation